Success Story: NIW Approved for Research Using Chemical Tools and Proteomics to Study Cancer Mechanisms
Client’s Testimonial:
“The experience of working with NAILG has been very smooth throughout the evaluation and material preparations. I spent a certain amount of time writing the research summary, and my work was recognized and articulated accurately by the lawyers: my research impacts were reflected coherently in my petition letter. I only needed to make small changes as most of the content was very well-presented. The processes of communication and preparing other supporting documents were also very smooth, as the instructions are very clear and the lawyers are meticulous with reviewing the package before sending it out. I felt reassured that there wouldn’t be any unnecessary delay due to preventable errors. Overall, I would recommend the service by NAILG to my friends and colleagues who are considering filing NIW or EB1A.”
On December 12th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Candidate in the field of Cancer Biology (Approval Notice).
General Field: Cancer Biology
Position at the Time of Case Filing: Ph.D Candidate
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: December 12th, 2025
Processing Time: 10 months, 18 days (Premium Processing Requested)
Case Summary:
USCIS approved this NIW petition on December 12, 2025, following 10 months and 18 days of processing (including a Premium Processing upgrade). At the time of filing, the client was a Ph.D. Candidate from China. NAILG presented the petition to demonstrate that the client’s continued work would serve the national interest.
A core strength of the case was the client’s research record and measurable influence. The client has documented their work in 9 peer-reviewed journal articles and 2 conference abstracts, and this published body of work has received 255 citations. This citation record reflects ongoing use of the client’s findings by independent researchers and supports the petition’s presentation of sustained impact.
The proposed endeavor focuses on using small molecules in proteomic and multi-omic techniques to advance understanding of cancer-relevant molecular pathways. The petition explained that this approach contributes to identifying and characterizing mechanisms central to disease progression, which supports broader efforts in basic cancer research and treatment development.
NAILG emphasized that this work has clear substantial merit and national importance because it advances foundational knowledge that can inform future therapeutic strategies. By applying advanced chemical tools to investigate molecular pathways relevant to cancer, the endeavor supports ongoing national priorities in biomedical innovation and public health.
Taken together, the approval, publication record, and citation impact demonstrated that the client is well-positioned to continue advancing the proposed endeavor. By organizing the evidence into a clear NIW framework, NAILG showed that waiving the job-offer requirement would benefit the United States by supporting continued progress in interdisciplinary biology research with relevance to cancer studies.